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Purpose: We evaluated the association between risk of obesity in the Portuguese  population 
and two obesity-related single-nucleotide gene polymorphisms: fat-mass and obesity-
 associated (FTO) rs9939609 and peroxisome proliferator-activated receptor gamma (PPARG) 
rs1801282.
Patients and methods: A total of 194 Portuguese premenopausal female Caucasians 
aged between 18 and 50 years (95 with body mass index [BMI] $30 g/m2, 99 controls with 
BMI 18.5–24.9 kg/m2) participated in this study. The association of the single-nucleotide 
polymorphisms with obesity was determined by odds ratio calculation with 95% confidence 
intervals.
Results: Significant differences in allelic expression of FTO rs9939609 (P,0.05) were found 
between control and case groups, indicating a 2.5-higher risk for obesity in the presence of both 
risk alleles when comparing the control group with the entire obese group. A fourfold-higher 
risk was found for subjects with class III obesity compared to those with classes I and II. No 
significant differences in BMI were found between the control and case groups for PPARG 
rs1801282 (P.0.05).
Conclusion: For the first time, a study involving an adult Portuguese population shows that 
individuals harboring both risk alleles in the FTO gene locus are at higher risk for obesity, which 
is in agreement to what has been reported for other European populations.
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Introduction
Obesity prevalence has grown dramatically in recent decades and shows no signs 
of decline. According to the World Health Organization (WHO), it is estimated that 
1.5 billion people are overweight, of which 500 million are obese.1 Obesity and over-
weight result from a combination of genetic background, environmental, and lifestyle 
factors, and are intrinsically associated with increased risk of associated disease, such 
as hypertension, dyslipidemia, and type 2 diabetes.2 Several gene-association stud-
ies have led to the identification of different loci (single nucleotide polymorphisms 
[SNPs]) that contribute to obesity and overweight.3 One of these SNPs, rs9939609, in 
the fat-mass and obesity-associated (FTO) gene, has been described as a risk factor to 
obesity, and strongly associated with body mass index (BMI) increments in European 
adults.4 Frayling and colleagues4 demonstrated that the presence of the risk allele A is 
cumulative and represent a 20% higher risk for the development of obesity and 13% 
for the development of overweight. This association was later confirmed by several 
other studies in different populations.5–7 Another gene playing an important role in 
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obesity is peroxisome proliferator-activated receptor gamma 
(PPARG), which regulates the adipocyte differentiation, 
thus influencing BMI, as well as glucose metabolism.8 In 
particular, SNP rs1801282 has been associated with obesity 
in different populations, with a clear identification of the 
risk allele G.9–11
To date, there are no data on the involvement of either 
of these SNPs in obesity in the adult Portuguese population, 
and whether the same pattern of risk alleles is present. Here, 
we report on the first association study between these SNPs 
and obesity for the adult Portuguese population, which can 
provide useful data for the clinical management and risk 
assessment of obesity.
Materials and methods
Subjects
All 194 subjects participating in the study were premeno-
pausal Caucasian Portuguese females between 18 and 
50 years old, duly informed about the study and having signed 
an informed consent.
As a control group were 99 healthy subjects showing a 
BMI ranging between 18.5 and 24.9 kg/m2 with body-weight 
variation inferior to 10% in the last year. These subjects were 
either selected during a routine health check or belonged to 
the staff of Curry Cabral Hospital (Lisbon, Portugal).
The case group was composed of 95 subjects showing a 
BMI $30 kg/m2 with body-weight variation inferior to 10% 
in the last year. These subjects were all attending the Endo-
crinology Department of Curry Cabral Hospital.
Sample collection
Samples were collected from peripheral total blood and pre-
served at −80°C. For analysis, 2 mL of blood was transferred 
to individual FTA (Whatman, Maidstone, UK) microcards, 
and DNA was purified according to the manufacturer’s 
protocol.
Polymorphism analysis
Polymerase chain reaction (PCR) amplifications were 
performed on a Biometra TGradient Thermocycler (Göt-
tingen, Germany) in 25 µL final volume with Master Mix 
and DNA Surf Hot Taq Polymerase (10 U/µL) (Stab Vida, 
Lisbon, Portugal) with the following thermal cycling condi-
tions: initial 15-minute denaturation at 96°C, followed by 30 
amplification cycles of denaturation at 94°C for 1 minute, 
annealing at 59°C for 1 minute, elongation at 70°C for 1 min-
ute, and a final elongation at 70°C for 5 minutes. Primers 
for PPARG locus (GenBank accession no NC_000003.11): 
PPARG-F 5′-CAATTCAAGCCCAGTCCTTT-3′ and 
PPARG-R 5′-TTATCTCTGTGCATGGCTCC-3′.  Primers 
for FTO locus (GenBank accession no NC_000016.9): 
FTO-F 5′-GCAAAATGGCAACACACACT-3′ and FTO-R 
5′-AACACCATCCTTGGGCTG-3′.
SNP identification was performed via direct sequencing. 
Sequencing reactions were carried out with 100 ng/100 bp 
of the previously PCR-amplified product using Big Dye 
version 3.1 technology (Life Technologies, Carlsbad, CA, 
USA) in an Applied Biosystems 3730XL DNA analyzer.
Statistical analysis
To determine the normality of the continuous variables 
(age), Student’s t-test was used. To determine the differ-
ences between genotype groups of each SNP and anthro-
pometric traits, one-way analyses of variance and a post 
hoc Bonferroni test were used. All odds ratio (OR) analysis 
was performed using binary logistic regression with 95% 
confidence interval (CI) to determine the risk of each loci to 
obesity and the respective P-value. All statistical analyses 
were carried out using SPSS software version 20 (IBM, 
Armonk, NY, USA).
Results
Table 1 presents the descriptive analyses of the subjects 
subdivided by their phenotype group. Figure 1 shows the 
population characterization by allele and genotype frequen-
cies for FTO and PPARG SNPs. Significant differences 
(P,0.05) were found only among the different genotypes of 
FTO rs9939609 for BMI, fat mass, and waist circumference. 
No other anthropometric traits were statistically different for 
FTO rs9939609 or PPARG rs1801282. Genotype frequen-
cies for FTO rs9939609 were 24.74% T/T, 56.70% A/T, and 
18.56% A/A. When comparing case and control groups, no 
significant deviation from the Hardy–Weinberg equilibrium 
of allele frequencies was observed for this locus (P=0.053), 
with a majority of individuals being heterozygous (A/T). Data 
showed that the T allele is more frequent in subjects with BMI 
values between 18.5 and 24.9 kg/m2, whereas the A allele is 
preeminent in subjects with BMI $30 kg/m2.
For PPARG rs1801282, the allele frequencies were 
80.93% for homozygous C/C, 1.03% for homozygous G/G, 
and 18.04% for heterozygous C/G. Again, no significant 
deviation from the Hardy–Weinberg equilibrium of allele 
frequencies was observed for PPARG rs1801282 (P=0.97).
The presence of the A allele in FTO rs9939609 does 
not per se confer risk for obesity in the studied  population. 
However, significant differences in allele frequencies between 
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the control and case groups were found for FTO rs9939609 
(P,0.05), indicating a 2.5-fold higher risk for obesity for 
homozygous A/A individuals (OR=2.571, CI 1.048–6.308; 
P=0.039). Comparison of homozygous A/A individuals with 
T allele carriers (either homozygous T/T or heterozygous 
A/T) clearly shows a significant association of homozygous 
A/A with obesity (OR=2.451, CI 1.145–5.243; P=0.021) 
(Table 2A).
What is more striking is the allelic expression of A/A 
homozygosity in subjects with a BMI $40 kg/m2, ie, class 
III obesity. Considering this subgroup of obese women com-
pared to those with class I and class II obesity, an OR=4.044 
(CI 1.099–14.878; P=0.035) was found (Table 2B).
Analysis of PPARG rs1801282 showed no association 
with obesity (P.0.05) within the studied population.
Discussion
The worldwide prevalence of obesity has been increasing dramat-
ically in the last few decades, and Portugal is no exception, where 
a 13.8% prevalence of obesity has been recorded.12 Association 
studies have highlighted the influence of SNPs in obesity, with 
particular focus on FTO rs9939609.13,14 Thus far, no data on the 
possible association of this SNP to obesity in the adult Portuguese 
population has been reported. Here, for the first time, we demon-
strate an association between the FTO rs9939609 homozygous 
AA genotype and increased BMI when compared to homozygous 
TT. Significant differences were found between control and case 
group confirming the increased risk for obesity of  homozygous 
AA at this locus. Also, with the post hoc Bonferroni test, it was 
Anthropometric measures
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Waist (cm)
Waist/hip ratio
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Figure 1 Population characteristics, in function of the respective genotype (upper). Genotype and allele frequencies (bottom) obtained for each single-nucleotide polymorphism. 
White bars – all subjects, grey bars – controls and black bars – case. (A) Genotype frequencies for fat-mass and obesity-associated (FTO) rs9939609; (B) allele frequencies for FTO 
rs9939609; (C) genotype frequencies for peroxisome proliferator-activated receptor gamma (PPARG) rs1801282; (D) allele frequencies for PPARG rs1801282.
Note: *Significant differences between groups were found for these cases.
Table 1 Anthropometric data of all subjects subdivided by 
phenotype
Anthropometric  
measures
Total Phenotype
Normal Obese
n 194 99 95
Age (years) 34.19 (±8.22) 34.24 (±8.30) 34.12 (±8.14)
BMI (kg/m2) 32.28 (±12.44) 21.42 (±1.69) 43.60 (±7.83)
Fat mass (kg) 33.59 (±22.43) 14.32 (±3.61) 54 (±14.88)
Fat mass (%) 36.22 (±12.25) 25.30 (±4.67) 47.61 (±5.30)
Waist (cm) 94.19 (±25.72) 71.75 (±5.85) 117.57 (±15.49)
Waist/hip ratio 0.80 (±0.09) 0.74 (±0.05) 0.87 (±0.08)
Notes: Obesity status: normal (BMI between 18.5 and 24.9 kg/m2), obese 
(BMI $ 30 kg/m2); all data presented as means ± standard deviation.
Abbreviation: BMI, body mass index.
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possible to determine that individuals with both A alleles in FTO 
rs9939609 show 6.37±2.35 (P=0.022) higher BMI, 11.99±4.86 
kg (P=0.043) higher body-fat mass and 13.31±4.87 cm (P=0.020) 
higher waist circumference compared to T-allele carriers. These 
data are in clear agreement with what has been reported for 
other populations of European origin.5–7,15,16 Our data show that 
in the adult Portuguese population, this polymorphism confers 
an even higher risk for class III obesity (BMI .40 kg/m2). This 
may allow identification of those individuals at increased risk and 
target them for an earlier clinical and lifestyle intervention. This 
idea has been recently reinforced by the report of Albuquerque 
and colleagues showing a strong association of FTO rs9939609 
with obesity in Portuguese children.17 Together, these data may 
prove useful for a structured public health strategy within the 
European Union.
Conversely, PPARG rs1801282 showed no association with 
obesity within the studied population, as no significant differ-
ence was found between control and case subjects (P.0.05). In 
European populations, PPARG rs1801282 has shown associa-
tion with obesity and higher BMI for homozygous carriers of 
the G allele (P,0.05).10 Nevertheless, no association was found 
in other studies,18–20 indicating that this SNP may differ between 
populations and probably should not be considered as a strong 
genetic marker to evaluate risk for obesity as FTO rs9939609 
is. Despite reports on a relation between PPARG rs1801282 
and diabetes type 2,21 we observed no relation in our study 
(P.0.05). The relevance of PPARG rs1801282 as a genetic 
marker to assess risk for obesity and high insulin levels in pre-
menopausal Portuguese women is, therefore, negligible.
Conclusion
Thus far, this is the first association study involving obesity-related 
genetic polymorphisms in the adult Portuguese population. 
Data show that FTO rs9939609 could be useful for the clinical 
management of obese women. Nevertheless, additional data are 
required, namely inclusion of males and youth subjects, to fully 
characterize the involvement of these loci in the development 
of obesity within the Portuguese population.
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